Most Clicked StoriesMore >


N.Y. officials recommend prioritizing Sovaldi treatment

PCMA SmartBrief | Sep 19, 2014

Health officials in New York recommend the state first treat the patients who need it most with the costly hepatitis C drug Sovaldi. People whose disease is advanced and those with serious comorbidities would have the highest treatment priority, under the recommendations, and patients would need to show "no signs of high-risk behavior" and indicators they would adhere to treatment. Capital New York (09/18)


N.Y. attorney general sues over switch to new drug

PCMA SmartBrief | Sep 16, 2014

Insurer expands value-based formulary to combat drug prices

PCMA SmartBrief | Sep 17, 2014

Drugmakers don't do enough to monitor copay coupons in Part D, HHS OIG says

PCMA SmartBrief | Sep 22, 2014

OIG: Changing Medicare Part B pharmacy fees to Part D model could have saved $111M

PCMA SmartBrief | Sep 17, 2014

Tiered pharmacy benefit plans remain popular

PCMA SmartBrief | Sep 16, 2014

PCMA: New OIG report cites drug manufacturer "copay coupon" use in Medicare Part D

PCMA SmartBrief | Sep 22, 2014

Drugmakers sow seeds of doubt about generics

PCMA SmartBrief | Sep 16, 2014

Group suggests ways for federal government to reduce opioid addiction

PCMA SmartBrief | Sep 17, 2014

Anti-obesity bill to boost access to drugs, counseling

PCMA SmartBrief | Sep 22, 2014


Find PCMA SmartBrief Issues by Date:





Sign up for PCMA SmartBrief



Designed specifically for PBM industry professionals, PCMA SmartBrief is a FREE, daily e-mail newsletter. It provides the the most relevant and actionable PBM industry news in a quick, easy to read format. Learn more